Evidence map›Paper›PMID 41711952›Full record

ArticleCurrent microbiology2026

Differential Copy Number of Chromosomal bla

Kai Kobayashi, Hiroaki Kubota, Tsukasa Ariyoshi, Yasunori Suzuki, Kohji Mori, Jun Suzuki, Yoshitsugu Ochiai, Kenji Sadamasu, Takashi Chiba

Abstract read
PubMed Publisher
In one paragraph

Article in Current microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kai KobayashiDepartment of Microbiology, Tokyo Metropolitan Institute of Public Health, Tokyo, Japan.ORCID http://orcid.org/0000-0003-4524-284X
Hiroaki KubotaDepartment of Microbiology, Tokyo Metropolitan Institute of Public Health, Tokyo, Japan. Hiroaki_Kubota@member.metro.tokyo.jp.ORCID http://orcid.org/0000-0002-6339-8568
Tsukasa AriyoshiDepartment of Microbiology, Tokyo Metropolitan Institute of Public Health, Tokyo, Japan.ORCID http://orcid.org/0000-0002-9294-5065
Yasunori SuzukiLaboratory of Veterinary Hygiene, Institute of Agriculture, Tokyo University of Agriculture and Technology, Tokyo, Japan.ORCID http://orcid.org/0000-0001-9278-0232
Kohji MoriDepartment of Microbiology, Tokyo Metropolitan Institute of Public Health, Tokyo, Japan.ORCID http://orcid.org/0000-0003-0521-4940
Jun SuzukiDepartment of Microbiology, Tokyo Metropolitan Institute of Public Health, Tokyo, Japan.ORCID http://orcid.org/0009-0006-2322-9176
Yoshitsugu OchiaiLaboratory of Veterinary Public Health, School of Veterinary Medicine, Faculty of Veterinary Science, Nippon Veterinary and Life Science University, Tokyo, Japan.ORCID http://orcid.org/0000-0002-4520-2031
Kenji SadamasuDepartment of Microbiology, Tokyo Metropolitan Institute of Public Health, Tokyo, Japan.ORCID http://orcid.org/0000-0003-0541-706X
Takashi ChibaDepartment of Microbiology, Tokyo Metropolitan Institute of Public Health, Tokyo, Japan.

Funding

Japan Society for the Promotion of Science 24K10230
6 · The paper itself

Abstract

Extended-spectrum β-lactamase-producing Enterobacterales pose a significant public health threat from a One Health perspective. During an investigation of companion dogs and cats in Tokyo, we isolated seven Escherichia coli sequence type ST38 strains with characteristic genetic structures related to cephalosporin resistance, as identified by genomic analysis. All strains carried one to three copies of blaCTX−M−14 on their chromosomes, with one strain carrying one copy on a plasmid. Among the six strains with only chromosomal copies, a higher copy number correlated with increased resistance to ceftazidime and elevated blaCTX−M−14 expression, whereas the doubling times calculated from growth curves remained unchanged. Continuous passaging in the presence of ceftazidime resulted in increased copy numbers in three of the six strains. Notably, these characteristics closely resembled those reported for E. coli strains isolated from human clinical cases in South Korea. This similarity suggests that the copy number amplification mechanisms in blaCTX−M−14-carrying E. coli are more widespread than previously recognized, extend across international borders, and adapt to diverse ecological niches, including those of companion animals. Given that an increased copy number enhances resistance to antimicrobial pressure, these findings highlight the need for prudent antimicrobial use in veterinary medicine.

Indexed as

beta-LactamasesCat DiseasesDNA Copy Number VariationsDog DiseasesEscherichia coliEscherichia coli InfectionsGene DosageAnimalsAnti-Bacterial AgentsCatsChromosomes, BacterialDogsMicrobial Sensitivity TestsPetsPlasmidsThird Generation CephalosporinsAnti-Bacterial Agentsbeta-lactamase CTX-M-14beta-LactamasesThird Generation Cephalosporins

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.